Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis

Abstract Background The therapeutic status of allogeneic stem cell transplantation (allo-SCT) as a post-remission treatment for patients with high-risk acute myeloid leukemia (AML) was well-accepted. However, the optimal treatment for patients with low/favorable- or intermediate-risk AML who achieve...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Wu Ye, Xia Wu, Ruying Zhao, Xuelian Jin, Hui Li, Ying Qu, Jie Ji, Zhigang Liu
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-05-01
Serija:	Stem Cell Research & Therapy
Teme:	Acute myeloid leukemia Allo-SCT Auto-SCT Chemotherapy Network-comparison
Online dostop:	https://doi.org/10.1186/s13287-024-03766-5
Oznake:	Označite Brez oznak, prvi označite!